Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report.
Adult
Aged
Aged, 80 and over
COVID-19
/ epidemiology
Cardiac Surgical Procedures
Disease Outbreaks
/ prevention & control
Female
Follow-Up Studies
Health Care Rationing
/ methods
Health Services Accessibility
/ organization & administration
Humans
Infection Control
/ methods
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Italy
Male
Middle Aged
Postoperative Complications
/ diagnosis
Tertiary Care Centers
COVID-19
SARS-CoV-2
cardiac surgery
new coronavirus
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
19
05
2020
revised:
24
09
2020
accepted:
28
09
2020
pubmed:
23
11
2020
medline:
24
2
2022
entrez:
22
11
2020
Statut:
ppublish
Résumé
The impact of coronavirus disease 2019 (COVID-19) on the postoperative course of patients after cardiac surgery is unknown. We experienced a major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in our cardiac surgery unit, with several patients who tested positive early after surgery. Here we describe the characteristics, postoperative course, and laboratory findings of these patients, along with the fate of the health care workers. We also discuss how we reorganize and reallocate hospital resources to resume the surgical activity without further positive patients. After diagnosis of the first symptomatic patient, surgery was suspended. Nasopharyngeal swabs were performed in all patients and health care workers. Patients who were positive for SARS-CoV-2 were isolated and monitored throughout the in-hospital stay and followed up after discharged until death or clinical recovery. Twenty patients were found to be positive for SARS-CoV-2 sometime after cardiac surgery (mean age 69 ± 10.4 years; median European System for Cardiac Operative Risk Evaluation II score 3 [interquartile range, 5.1]); the median time from surgery to diagnosis was 15 days (interquartile range, 11). Among the patients, 18 had undergone cardiac surgery and 2 of them transcatheter aortic valve replacement. Overall mortality was 15%. Specific COVID-19-related symptoms were identified in 7 patients (35%). Among the 12 health care workers infected, 1 developed a bilateral mild-grade interstitial pneumonia. COVID-19 infection after cardiac surgery, regardless the time of the onset, is a serious condition. The systemic inflammatory state that follows extracorporeal circulation may mask the typical COVID-19 laboratory findings, making the diagnosis more difficult. A strict reorganization of the hospital resources is necessary to safely resume the cardiac surgical activity.
Identifiants
pubmed: 33220960
pii: S0022-5223(20)32872-5
doi: 10.1016/j.jtcvs.2020.09.138
pmc: PMC7581347
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1085-1092.e3Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Références
Lancet Respir Med. 2020 Apr;8(4):e24
pubmed: 32178774
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1025-1028
pubmed: 32301984
Crit Care. 2020 May 8;24(1):205
pubmed: 32384917
Ann Thorac Surg. 1999 Sep;68(3):1107-15
pubmed: 10510030
Ann Thorac Surg. 2020 Aug;110(2):697-700
pubmed: 32305286
J Card Surg. 2020 Jun;35(6):1177-1179
pubmed: 32333437
Ann Thorac Surg. 2020 Nov;110(5):e405-e407
pubmed: 32333849
J Thorac Cardiovasc Surg. 1987 Jun;93(6):860-6
pubmed: 3494886
J Thorac Cardiovasc Surg. 2020 Oct;160(4):968-973
pubmed: 32505456
Int J Infect Dis. 2005 Nov;9(6):323-30
pubmed: 16095942
Ann Thorac Surg. 2007 Sep;84(3):823-8
pubmed: 17720383
Int J Cardiol. 2007 Aug 9;120(1):108-14
pubmed: 17141340
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Heart Surg Forum. 2020 Apr 21;23(2):E231-E233
pubmed: 32364920
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
Can J Cardiol. 2020 Jul;36(7):971-976
pubmed: 32380228
Ann Thorac Surg. 1998 Mar;65(3):712-8
pubmed: 9527200
Clin Exp Immunol. 1999 Feb;115(2):315-23
pubmed: 9933459
J Cardiothorac Vasc Anesth. 2009 Apr;23(2):223-31
pubmed: 18930659
Eur J Cardiothorac Surg. 2003 Aug;24(2):260-9
pubmed: 12895618
Can J Anaesth. 1994 Sep;41(9):876-7
pubmed: 7525092